01Principles and purposeThe professional or clinical skill and the decisions it supports.
Triple assessment combines three different kinds of evidence: clinical examination defines the presentation, mammography or ultrasound maps morphology and extent, and image-guided biopsy samples tissue when indicated. The value lies in integration. Three reports are not concordant merely because all three have been completed, especially when they describe different coordinates or when the biopsy did not retrieve the imaging target.
Diagnostic closure requires one explanation that accounts for every management-relevant abnormality. A benign core can close a benign-looking, accurately sampled lesion; the same words cannot close a spiculated mass when targeting was uncertain. Multiple lesions need separate labels and separate concordance decisions. Discordance is resolved through image review, pathology review and representative repeat or surgical sampling agreed by the multidisciplinary team.
Key points
- Triple assessment integrates clinical examination, appropriate breast imaging and image-guided histological sampling when the abnormality requires tissue diagnosis.
- Each component must address the same lesion; three completed reports do not create concordance if their sites or explanations differ.
- Mammography and ultrasound contribute morphology and distribution, while clinical examination supplies the symptom map and pathology supplies sampled biology.
- A benign core is reassuring only when the specimen is representative and its diagnosis plausibly explains the clinical and radiological appearances.
- Indeterminate, high-risk or discordant findings need multidisciplinary resolution through additional imaging, repeat biopsy, vacuum-assisted excision or surgery as appropriate.
- The patient should receive one integrated outcome, including residual uncertainty and the next step, rather than independent messages from separate departments.
02Situations and prioritiesThe context, relevant information and actions that matter most.
Clinical findings estimate context and urgency, imaging characterises and maps the lesion, and pathology samples its biology; none is automatically decisive when the others disagree.
A complete set of reports is not enough. The team must decide whether every component refers to the same target and whether the combined explanation accounts for the presentation.
Needle biopsy is performed when indicated by the clinical or imaging abnormality and should target the relevant lesion under image guidance whenever that improves accuracy.
Results need a named review process, an explicit outcome and a plan for indeterminate or high-risk lesions; unexplained persistence should not disappear between departments.
03Assessment and interpretationHow to gather information, assess the situation and recognise uncertainty.
Consider the information, its meaning and its limitations before deciding what follows.
- 01
Clinical component - Why
- Localise the symptomatic or screen-detected target and define associated signs.
- Interpretation and limitations
- A normal examination can coexist with mammographic abnormality, while a concerning palpable lesion can require resolution despite initially benign imaging.
- 02
Mammography and ultrasound - Why
- Provide complementary morphological information and enable targeted comparison.
- Interpretation and limitations
- Imaging category expresses suspicion, not tissue identity; age and presentation influence modality, and technically adequate views must cover the relevant area.
- 03
Image-guided needle biopsy - Why
- Provide histology for a lesion that requires pathological diagnosis.
- Interpretation and limitations
- Core results are interpreted with sampling adequacy and target accuracy; a result that cannot explain the imaging finding is discordant rather than simply negative.
- 04
Multidisciplinary concordance review - Why
- Integrate all components and select discharge, surveillance, repeat biopsy or treatment.
- Interpretation and limitations
- Review must identify the exact lesion, laterality and result category; multiple abnormalities may each need separate concordance decisions.
04Worked approachesCases with ordered reasoning, an action and a check of the outcome.
01Worked case: integrated breast assessmentApply triple assessment principles to a defined presentationScreening mammography shows architectural distortion. Ultrasound finds a subtle correlate, core biopsy returns benign fibrosis, and the distortion remains unexplained on review.+
- 1Confirm that clinical examination, mammographic distortion, ultrasound target and specimen location all refer to the same area rather than assuming they are interchangeable.
- 2Ask pathology whether the sampled benign fibrosis is an adequate explanation and radiology whether the clip or biopsy track confirms accurate targeting.
- 3Classify the outcome as discordant when the pathology does not explain the suspicious architecture, then agree repeat vacuum-assisted or surgical sampling in the multidisciplinary team.
- 4Give the patient the integrated conclusion and next procedure, including why the benign words on one report have not ended the assessment.
- 5Verify that additional histology is reviewed against the original images and that a final documented concordance decision is assigned.
02Concordance conferenceTest whether all components explain one targetClinical, imaging and pathology reports are available for a suspicious breast abnormality.+
- 1Place the clinical map, imaging finding, biopsy route and marker position side by side and verify that each refers to the same laterality and lesion.
- 2Ask whether the pathological tissue is adequate and whether its diagnosis accounts for the morphology; normal tissue cannot explain a spiculated mass unless the target was misidentified.
- 3Assign a concordance outcome and specify why: benign concordant, malignant concordant, indeterminate requiring further sampling, or discordant requiring resolution.
- 4Record the agreed action and who will communicate it; avoid leaving the patient to interpret one favourable line from a conflicting set of reports.
03Multiple-target pathwayAssess separate abnormalities separatelyImaging shows a second abnormal focus in addition to the palpable lesion that prompted referral.+
- 1Label each target independently with side, position, modality and assessment category so samples and reports cannot be mistakenly interchanged.
- 2Decide whether the second focus changes diagnosis or surgery enough to require its own image-guided biopsy before treatment planning.
- 3Review both pathology results against their matching images; concordance for one lesion says nothing about the unsampled second lesion.
- 4Give a combined treatment or surveillance plan only after every management-relevant target has a documented explanation.
05Feedback, follow-up and evidenceReview outcomes, seek feedback and identify what to improve.
- Maintain a target table for laterality, location, imaging category, biopsy method and pathology category when more than one lesion is present.
- Record specimen adequacy, retrieval of calcification where relevant and marker position before accepting a pathology result as representative.
- Track B3, inadequate and discordant results to the breast multidisciplinary meeting and then to the procedure selected for resolution.
- Confirm that the patient has received the integrated assessment outcome and knows whether the diagnosis is final, provisional or awaiting more tissue.
06Special situationsVariants, exceptions and circumstances that change the usual approach.
Concordance is an active judgment
Agreement is not produced by majority vote. A benign clinical impression and core cannot neutralise unexplained suspicious distortion; the team asks whether one diagnosis genuinely explains all evidence.
Pathology answers a sampling question
A core report describes the material in the pot. Radiology must establish that the needle sampled the intended lesion, especially for small calcifications, distortion or multiple adjacent targets.
The weakest component can matter most
One clearly discordant component can expose target error despite two reassuring findings. Diagnostic safety comes from investigating that mismatch rather than averaging categories.
Process supports psychological safety
An integrated explanation prevents patients hearing both benign and suspicious without context. State why more sampling is needed and what new evidence will allow a final decision.
07Common pitfallsFrequent interpretation and management errors.
- 01
Treating triple assessment as a checklist ignores whether the components examined the same lesion and reached a coherent explanation.
- 02
Using a two-out-of-three rule can falsely reassure when the minority finding represents the correctly targeted suspicious abnormality.
- 03
Reporting a benign biopsy without discussing adequacy or imaging correlation mistakes sampled tissue for the whole lesion.
- 04
Failing to label multiple targets by laterality and position can attach the right pathology to the wrong abnormality.